Shares in Novo Nordisk NOVOb.CO rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its bid for U.S.

US drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war ...

The decision comes amid a leadership shakeup at the Danish drugmaker. Current chair Helge Lund and six other independent ...

Pfizer has successfully secured a $10 billion deal to acquire Metsera, a prominent developer of obesity drugs, after an ...

Get the daily news here. Read the essential Danish news and topics of today - in English. Politiken Edition is your window to ...

Competition is working, even as the FTC meddles in a takeover fight in a way that helped Pfizer.

Metsera said it expects the Pfizer deal to close promptly after a stockholder meeting scheduled for this coming Thursday ...

Investing.com - U.S. stock futures rose sharply Monday after the Senate voted in favor of a bill aimed at ending the ...

US pharma giant Pfizer won a bidding war to acquire obesity drug developer Metsera, beating back an offer from Danish rival ...

Shares of Novo Nordisk increased after the company withdrew its bid for U.S. weight loss drug maker Metsera, allowing Pfizer to secure a $10 billion deal. This move grants Pfizer entry into the ...

Welcome back! For the first time in a while, the U.S. stock market is falling. The S&P 500 Index has shed 4% from its peak on October 29, while the tech-heavy Nasdaq Composite Index is down 6%. Is ...

U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss ...